https://www.selleckchem.com/pr....oducts/toyocamycin.h
Results RAPA treatment significantly improved the body mass and clinical scores in EAMG rats. Compared with the CFA group, the number of Th17 cells in the spleen of the EAMG group increased, and the number of Tregs decreased. Compared with the EAMG group, the number of Th17 cells in the spleen of RAPA-treated rats significantly dropped, the number of Tregs went up, and the level of anti-R97-116 antibodies in the serum went down. RAPA treatment inhibited the proliferation of lymphocytes induced by RPMI1640 medium, R97-116, and ConA s
Like
Comment
Share
